Intimation regarding the trading and admission to dealings of the Company''s Equity Shares on the National Stock Exchange of India Limited, is attached.
DRAGARWQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr Agarwals Eye Hospital, which was so far listed only on BSE under scrip code 526783, has been permitted to trade on NSE w.e.f. April 20, 2026 under the symbol 'DRAGARWQ'. The company clarifies that this is an exchange-led action initiated by NSE under its 'Permitted to Trade' framework, and not a corporate action by the company. Importantly, Dr Agarwals has not filed any formal listing application with NSE nor signed a listing agreement. The stock continues to be listed on BSE with full compliance of all listing obligations there.
Shareholders gain access to NSE's much larger trading platform, which should improve liquidity and price discovery. However, since there is no formal NSE listing agreement, the company is not bound by NSE's full disclosure norms, and this is a low-key administrative change rather than a major corporate event — no immediate fundamental impact is expected.